the Voting Panel did not vote on recommendations regarding weight loss interventions specifically for RA management in overweight or obese people with RA. However, the Voting Panel was unanimous in its support of clinicians engaging in discussion about maintaining a healthy body weight for individuals with RA, in order to optimize long-term RA and general health outcomes. In RA, obesity is associated with higher disease activity, impairments in physical function, and poorer treatment response,